1. Home
  2. BPMC vs TX Comparison

BPMC vs TX Comparison

Compare BPMC & TX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPMC
  • TX
  • Stock Information
  • Founded
  • BPMC 2008
  • TX 1961
  • Country
  • BPMC United States
  • TX Luxembourg
  • Employees
  • BPMC N/A
  • TX N/A
  • Industry
  • BPMC Biotechnology: Pharmaceutical Preparations
  • TX Steel/Iron Ore
  • Sector
  • BPMC Health Care
  • TX Industrials
  • Exchange
  • BPMC Nasdaq
  • TX Nasdaq
  • Market Cap
  • BPMC 5.8B
  • TX 5.9B
  • IPO Year
  • BPMC 2015
  • TX 2006
  • Fundamental
  • Price
  • BPMC $97.17
  • TX $28.52
  • Analyst Decision
  • BPMC Buy
  • TX Buy
  • Analyst Count
  • BPMC 21
  • TX 3
  • Target Price
  • BPMC $124.05
  • TX $41.00
  • AVG Volume (30 Days)
  • BPMC 973.2K
  • TX 187.7K
  • Earning Date
  • BPMC 05-01-2025
  • TX 04-29-2025
  • Dividend Yield
  • BPMC N/A
  • TX 9.53%
  • EPS Growth
  • BPMC N/A
  • TX N/A
  • EPS
  • BPMC N/A
  • TX N/A
  • Revenue
  • BPMC $562,121,000.00
  • TX $16,803,571,000.00
  • Revenue This Year
  • BPMC $44.85
  • TX N/A
  • Revenue Next Year
  • BPMC $32.06
  • TX $6.35
  • P/E Ratio
  • BPMC N/A
  • TX N/A
  • Revenue Growth
  • BPMC 99.19
  • TX N/A
  • 52 Week Low
  • BPMC $73.04
  • TX $24.00
  • 52 Week High
  • BPMC $121.90
  • TX $43.93
  • Technical
  • Relative Strength Index (RSI)
  • BPMC 59.54
  • TX 46.83
  • Support Level
  • BPMC $87.03
  • TX $28.68
  • Resistance Level
  • BPMC $104.86
  • TX $30.33
  • Average True Range (ATR)
  • BPMC 3.86
  • TX 0.79
  • MACD
  • BPMC 1.24
  • TX 0.12
  • Stochastic Oscillator
  • BPMC 64.38
  • TX 42.54

About BPMC Blueprint Medicines Corporation

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.

About TX Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)

Ternium SA is a flat steel producer operating in Mexico, Brazil, Argentina, Colombia, the southern United States, and Central America. It produces finished and semi-finished steel products and iron ore, which are sold either directly to steel manufacturers and steel processors or end-users. The company operates in two segments: Steel, Usiminas and Mining. In its steel segment, the company produces slabs, billets & round bars, hot-rolled coils & sheets, bars & stirrups, wire rods, steel pipes, and other products. The Mining segment sells iron ore as concentrates (fines) and pellets. The Usiminas segment include iron ore extraction, steel transformation, production of capital goods and logistics. The vast majority of its revenue comes from the steel segment and geographically from Mexico.

Share on Social Networks: